SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

insitro, Lilly make machine learning models for pharmacokinetic behavior prediction available

insitro and Eli Lilly and Company have made advanced machine learning models available in Lilly TuneLab™ that predict in vivo properties of small molecules. Trained on decades of Eli Lilly's preclinical data, the models offer an alternative to traditional industry standard methods.